"10.1371_journal.pone.0028115","plos one","2012-01-03T00:00:00Z","Luis F López-Cortés; Rosa Ruiz-Valderas; Luis Jimenez-Jimenez; María F González-Escribano; Almudena Torres-Cornejo; Rosario Mata; Antonio Rivero; Juan A Pineda; Manuel Marquez-Solero; Pompeyo Viciana; on behalf of Grupo para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas","Unidad Clínica de Enfermedades Infecciosas, Hospitales Universitarios Virgen del Rocío/Instituto de Biomedicina de Sevilla, Seville. Spain; Servicio de Bioquímica Clínica, Hospitales Universitarios Virgen del Rocio, Seville, Spain; Servicio de Inmunología, Hospitales Universitarios Virgen del Rocío/Instituto de Biomedicina de Sevilla, Seville, Spain; Unidad Clínica de Enfermedades Infecciosas, Hospital Universitario Reina Sofia, Córdoba, Spain; Unidad Clínica de Enfermedades Infecciosas, Hospital Universitario de Valme, Seville, Spain; Unidad Clínica de Enfermedades Infecciosas, Hospital Universitario Virgen de la Victoria, Málaga, Spain","Conceived and designed the experiments: LL-C. Analyzed the data: LL-C RR-V LJ-J MG-E AT-C RM AR JP MM-S PV. Wrote the paper: LL-C. Provision and follow-up of patients: LL-C AT-C RM AR JP MM-S PV. PegIFN-α-2a plama levels: LJ-J RR-V. Ribavirin plasma levels: RR-V. rs129679860 SNP genotype: AT-C MG-E. Critical revision of the manuscript for important intellectual content: RR-V LJ-J MG-E AT-C RM AR JP MM-S PV. Final approval of the manuscript: RR-V LJ-J MG-E AT-C RM AR JP MM-S PV. Obtaining of funding: LL-C.","LL-C, PV, F. Lozano, and AR have received honoraria for speaking at symposia organized on behalf of Abbott laboratories (Spain), Bristol-Myers Squibb, GlaxoSmithkline, Gilead Sciences, Janssen-Cilag España, Merck Sharp & Dohme España, Roche Pharma SA; and have also received unrestricted funds for research from Abbott Laboratories (Spain), Bristol-Myers Squibb, Boehringer Ingelheim España S.A, GlaxoSmithkline, and Roche Pharma SA. Other authors: none to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.","2012","01","Luis F López-Cortés","LFLC",11,TRUE,1,NA,10,1,FALSE,FALSE,TRUE,2,"1;4",TRUE
